Suchergebnisse - "Shirabe, Ken"

PubPharm (34)

1

Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer

enthalten in: Medical molecular morphology | 2024

von Narusawa, E. | Kurozumi, S. | Katayama, A. | +9

2

Preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer

enthalten in: Esophagus : official journal of the Japan Esophageal Society | 2023

von Watanabe, T. | Sohda, M. | Kim, M. | +12

3

Preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer

enthalten in: Esophagus | 2022

von Watanabe, T. | Sohda, M. | Kim, M. | +12

4

Preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer

enthalten in: Esophagus | 2022

von Watanabe, T. | Sohda, M. | Kim, M. | +12

5

Preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer

enthalten in: Esophagus | 2022

von Watanabe, T. | Sohda, M. | Kim, M. | +12

6

Impact of the Ratio of Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer

enthalten in: Annals of surgical oncology | 2022

von Sakai, M. | Sohda, M. | Uchida, S. | +11

7

Impact of the Ratio of Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer

enthalten in: Annals of surgical oncology | 2022

von Sakai, M. | Sohda, M. | Uchida, S. | +11

8

Impact of the Ratio of Visceral Fat Area (VFA) to Psoas Muscle Area (PMA) (V/P Ratio) on Survival for Surgically Resected Esophageal Cancer

enthalten in: Annals of surgical oncology | 2022

von Sakai, M. | Sohda, M. | Uchida, S. | +11

9

Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response

enthalten in: Anticancer research | 2022

von Harimoto, N. | Itoh, S. | Yamanaka, T. | +7

10

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma : a retrospective in silico analysis of public datasets

enthalten in: Breast cancer research : BCR | 2020

von Kurozumi, S. | Alsaleem, M. | Monteiro, C. | +12